Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor for Stem Cell Mobilization in MM and NHL
NCT00322387Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), sponsored by Sanofi. Started Apr 2004; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00322387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322387.